Abeona Therapeutics Shares Outstanding 2010-2022 | ABEO

Abeona Therapeutics shares outstanding from 2010 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Abeona Therapeutics Annual Shares Outstanding
(Millions of Shares)
2021 98
2020 93
2019 50
2018 48
2017 42
2016 34
2015 28
2014 2
2013 1
2012 0
2011 0
2010 0
2009 0
Abeona Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2022-03-31 145
2021-12-31 98
2021-09-30 98
2021-06-30 97
2021-03-31 94
2020-12-31 93
2020-09-30 93
2020-06-30 93
2020-03-31 92
2019-12-31 50
2019-09-30 50
2019-06-30 49
2019-03-31 48
2018-12-31 48
2018-09-30 48
2018-06-30 47
2018-03-31 47
2017-12-31 42
2017-09-30 40
2017-06-30 40
2017-03-31 40
2016-12-31 34
2016-09-30 33
2016-06-30 33
2016-03-31 33
2015-12-31 28
2015-09-30 32
2015-06-30 26
2015-03-31 20
2014-12-31 2
2014-09-30 1
2014-06-30 1
2014-03-31 1
2013-12-31 1
2013-09-30 1
2013-06-30 1
2013-03-31 1
2012-12-31 0
2012-09-30 0
2012-06-30 0
2012-03-31 0
2011-12-31 0
2011-09-30 0
2011-06-30 0
2011-03-31 0
2010-12-31 0
2010-09-30 0
2010-06-30 1
2010-03-31 0
2009-12-31 0
2009-09-30 0
2009-06-30 0
2009-03-31 0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.022B $0.003B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $164.215B 9.99
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.343B 16.33
Biohaven Pharmaceutical Holding (BHVN) United States $10.057B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.540B 0.00
Emergent Biosolutions (EBS) United States $1.675B 7.17
Arcus Biosciences (RCUS) United States $1.287B 32.64
Myovant Sciences (MYOV) United Kingdom $0.927B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.347B 0.00
Zymeworks (ZYME) Canada $0.336B 0.00
Ambrx Biopharma (AMAM) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.113B 23.10
SQZ Biotechnologies (SQZ) United States $0.094B 0.00